Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  donor regulatory T lymphocytes
Find trials that include:  Any drugs shown
Results 1-4 of 4 for your search:
Start Over
T-Regulatory Cells in Preventing Graft-Versus-Host Disease After Double Umbilical Cord Blood Transplant in Patients With Hematological Malignancies
Status: Not yet active
Phase: Phase II
Type: Supportive care, Treatment
Age: 18 to less than 70
Trial IDs: MT2013-27, NCI-2014-00399, 2013LS091, NCT02118311
Donor Regulatory T Lymphocytes and Aldesleukin in Treating Patients with Steroid-Refractory Chronic Graft-versus-Host Disease following Donor Stem Cell Transplant
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: 13-281, NCI-2013-02261, IIT13PLK04, NCT01937468
Ex-Vivo Expanded Donor Regulatory T Cells for Prevention of Acute Graft-versus-Host Disease
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention, Treatment
Age: 18 to 70
Trial IDs: 17263, NCI-2014-01426, MCC-17263, NCT01795573
Donor Regulatory T Cells in Treating Patients with Visceral Acute Graft-versus-Host Disease after Stem Cell Transplant
Status: Temporarily closed
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: BMT267, NCI-2014-01609, 30861, NCT02526329
Start Over